Bata India Ltd. (BIL)

Transcription

1 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Q2FY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Bata India Ltd. (BIL) Cloudy quarter sunshine ahead; maintain BUY Bata India Ltd. (BIL) reported 2QFY16 result with revenue growth of 5% YoY to Rs 5.7bn and EBITDA declined by ~23 YoY to Rs.491mn due to weak demand, supply chain issue, higher discounts & promotional costs. Reported PAT increased by ~39% YoY to Rs.541mn vs Rs.390mn mainly due to gain from exceptional items. Sluggish revenue growth: BIL s topline increased only by 5% YoY to Rs.5.7bn in 2QFY16 due to lower consumer sentiment, weak demand and supply chain issue. However, the company is currently widening its product portfolio; training its staff to improve the quality of shopping experience; putting efforts towards solving the implementation of SAP/ERP systems. With all these measures, the company is expected to recover and show a healthy growth in revenue going forward. We expect the company to maintain the growth rate at CAGR of ~11.6% over FY15-18E backed by volume growth, strengthening e-commerce business and enhanced versatility in its product portfolio. A ~308 bps declined in EBIDTA margin to 8.5% v/s 11.6% YoY: BIL s EBITDA margin declined by ~308 bps YoY to 8.5% as against 11.6% in 2QFY15. EBITDA for 2QFY16 stood at Rs.491mn v/s Rs.636mn in 2QFY16 a decline of ~23%/43% YoY/QoQ respectively mainly due to high rental costs, increase in other expenses & many promotional schemes to liquidate the inventory. Price Price Target Up/Down (%) Rs. 476 Rs. 571 Bloomberg Code BATA: IN Share Holding (%) BATA.NS Promoters 52.9 FII DIIs Stock Data Sector: Footwear 18 th Nov, % Reuters Code As on 30th September 2015 Nifty 7,732 Sensex 25, week high/low 748/458 Maket Cap (Rs. bn) 61.2 Face Value Rs. 5 Price performance (%) 1M 3M 6M 1Y Absolute Relative to Sensex Reported PAT grew by ~39% YoY: BIL s reported PAT grew by ~39% YoY to Rs.541mn but adjusted profit (excluding exceptional items) declined by ~42% YoY to Rs.224mn in 2QFY16 as against Rs.390mn in 1QFY15. Exceptional items represent gain from sale of trademark (Sparx) of Rs.60.8cr and expenditure incurred (except the expenditure on perpetual license) amounting to Rs.29.1cr on setbacks in implementation of ERP system. Focusing on premiumisation: BIL is the largest footwear retailer in India with a high market share in the organized sector. The Company has strong pan-india presence with ~1,265 Shoe Stores located in over 500 cities. Of these there are 1,121 Bata, 102 Hush Puppies and 42 Footin Stores. In order to improve volume and profitability the company is focusing on rationalizing its stores; opening ~70-73 new exclusive outlets of premium brands like Hush Puppies, Naturalizer and Marie Claire in FY16. Strengthening online presence: BIL is strengthening its online presence by launching exclusive online portfolio, which will help in augmenting its online presence and also set up uniqueness amidst high competition. Relative Performance Source:-Bloomberg Bata India BSE Sensex Valuation: Although the company had a slow growth due to teething problem in supply chain and lower consumer sentiments, we still believe that BIL would be back on track and poised for strong growth on account of premiumisation, expansions of product ranges, strengthening online presence and distribution network. At CMP of Rs.476, the stock is trading at around 37.4/32.4/25x of FY16/17/18e. We maintain BUY rating with target price of Rs.571 (upside 20%). Exhibit 1: Financial summary (Rs mn) Year end: March CY13 FY15(15M) FY16 FY17 FY18 Net sales 20,652 26,940 23,726 26,574 30,560 Growth (%) Operating margin (%) PAT 1,909 2,313 1,637 1,887 2,448 Adjusted PAT 2,010 1,997 1,637 1,887 2,448 EPS (Rs) P/E(x) ROE (%) ROCE (%) Akanksha Tripathi akanksha.tripathi@bobcaps.in

2 Exhibit 2: Q2FY16 Quarterly financials (Rs Mn) 2QFY16 3QFY15 YoY (%) 1QFY16 Net Sales 5,752 5, , Other Related Income Total Income 5,754 5,480 6,805 Total Expenses 5,263 4,844 5,941 (%) of net sales 91% 88% 87% (Increase)/ decrease in stock Raw material consumed 971 1,012 1,127 (%) of net sales 17% 18% 17% Staff cost (%) of net sales 12% 12% 10% Manufacturing & Other Expenses 1,899 1,680 1,762 (%) of net sales 33% 31% 26% EBITDA EBITDA Margin Depreciation EBIT Interest Other Income PBT Less: Taxation Tax / PBT 41% 33% 34% Recurring PAT Exceptional items (income)/expense Less: Minority Interest Reported PAT NPM 9.4% 7.1% 13.6% Source: Company, BOBCAPS FY15 includes 15 months as the company changed its financial year-end from December to March. QoQ (%) Equity research 2

3 Financials Exhibit 3: Income Statement Net sales 20,652 26,940 23,726 26,574 30,560 growth (%) COGS 3,346 4,284 3,991 4,390 4,859 Staff Cost 2,133 3,119 2,610 3,056 3,667 R&D Cost (1,186) (1,106) (1,186) (1,329) (1,528) SG&A Cost 13,139 17,294 15,517 17,220 19,405 EBITDA 3,220 3,349 2,795 3,237 4,156 growth (%) 17 (0) (17) Depreciation EBIT 2,627 2,557 2,097 2,455 3,257 Other income Interest paid Extraordinary/Exceptional items (101) PBT 2,829 3,287 2,434 2,807 3,642 Tax ,195 Minority interest PAT 1,909 2,312 1,636 1,886 2,447 Non-recurring items 101 (315) Adjusted PAT 2,010 1,996 1,636 1,886 2,447 Exhibit 4: Balance Sheet Cash & Bank balances 2,558 2,101 1,882 1,798 1,708 Other Current assets 7,862 9,824 9,896 11,119 12,671 Investments Net fixed assets 3,393 4,436 5,446 6,666 7,864 Intangible assets Total assets 13,820 16,370 17,240 19,602 22,264 Current liabilities 3,738 4,418 4,171 4,971 5,620 Borrowings ,017 1,078 1,079 Other non-current liabilities Current/Non-current liabilities 5,421 6,158 5,832 6,816 7,689 Share capital Reserves & surplus 7,756 9,569 10,765 12,143 13,932 Shareholders' funds 8,399 10,212 11,407 12,786 14,574 Total liabilities 13,820 16,370 17,240 19,602 22,264 Equity research 3

4 Exhibit 5: Cash Flow Statement Profit after tax 1,909 2,312 1,636 1,886 2,447 Depreciation Chg in working capital (618) (1,411) (437) (300) (680) Total tax paid (237) Net Extra-ordinary income 101 (315) Cash flow from operations 1, ,421 1,845 2,065 Capital expenditure (455) (1,181) (1,232) (1,479) (1,496) Change in investments Acquisition of Goodwill (1) (2) (7) (3) (1) Cash flow from investments (457) (1,182) (1,239) (1,482) (1,497) Free cash flow 1,051 (263) Issue of shares Net inc/dec in debt Dividend (incl. tax) (489) (489) (440) (508) (658) Other financing activities 225 (10) 0 0 (0) Net Extra-ordinary income (101) Cash flow from financing (32) (314) (401) (447) (657) Inc/(Dec) in Cash & Bank bal. 918 (262) (219) (84) (90) Exhibit 6: Ratio analysis Y/E Mar CY13 FY15(15M) FY16 FY17 FY18 Per share data (Rs) EPS CEPS DPS BV Profitability ratios (%) Gross margins Operating margins Net margins Valuation ratios (x) PE P/BV EV/EBITDA EV/Sales RoE RoCE RoIC Equity research 4

5 Sales and Dealing Team Purvesh Shelatkar Senior Vice President & Head Equity Anil Pawar Senior Manager Dealing Sachin Sambare Manager Dealing /33 Ashwin Patil Executive Dealing Research Team Sectors Vaishali Parkar Kumar Analyst Agri, Auto, Defence Padmaja Ambekar Analyst Auto Ancillary, Infra, Midcap Akanksha Tripathi Analyst Footwear, FMCG Rishabh Mehta Associate Hareesha Kakkera Associate UTI Tower, 3rd Floor, South Wing, Bandra-Kurla Complex, Bandra (E), Mumbai India. Ph.: Fax: research@bobcaps.in Web: NSE SEBI No. (CASH): INB NSE SEBI No. (DERIVATIVES): INF BSE SEBI No. : INB Disclaimer BUY. We expect the stock to deliver >15% absolute returns. HOLD. We expect the stock to deliver 5-15% absolute returns. SELL. We expect the stock to deliver <5% absolute returns. Not Rated (NR). We have no investment opinion on the stock. The BoB Capital Markets research team hereby certifies that all of the views expressed in this report accurately reflect our personal views about the subject company or companies and its or their securities. We also certify that no part of our compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report." BOB Capital Markets Ltd. generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, BOB Capital Markets Ltd. generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Additionally, other important information regarding our relationships with the company or companies that are the subject of this material is provided herein. This material should not be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. We are not soliciting any action based on this material. It is for the general information of clients of BOB Capital Markets Ltd. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, clients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. BOB Capital Markets Ltd. does not provide tax advice to its clients, and all investors are strongly advised to consult with their tax advisers regarding any potential investment in certain transactions including those involving futures, options, and other derivatives as well as non-investment-grade securities that give rise to substantial risk and are not suitable for all investors. The material is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied on as such. Opinions expressed are our current opinions as of the date appearing on this material only. We endeavor to update on a reasonable basis the information discussed in this material, but regulatory, compliance, or other reasons may prevent us from doing so. We and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance of this material, may from time to time have "long" or "short" positions in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein and may from time to time add to or dispose of any such securities (or investment). We and our affiliates may act as market maker or assume an underwriting commitment in the securities of companies discussed in this document (or in related investments), may sell them to or buy them from customers on a principal basis and may also perform or seek to perform investment banking or advisory services for or relating to those companies and may also be represented in the supervisory board or any other committee of those companies. For the purpose of calculating whether BOB Capital Markets Ltd. and its affiliates hold, beneficially own, or control, including the right to vote for directors, 1% or more of the equity shares of the subject, the holding of the issuer of a research report is also included. BOB Capital Markets Ltd. and its non-us affiliates may, to the extent permissible under applicable laws, have acted on or used this research to the extent that it relates to non-us issuers, prior to or immediately following its publication. Foreign currency denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies, affectively assume currency risk. In addition, options involve risks and are not suitable for all investors. Please ensure that you have read and understood the current derivatives risk disclosure document before entering into any derivative transactions. In the US, this material is only for Qualified Institutional Buyers as defined under rule 144(a) of the Securities Act, 1933.No part of this material may be (i) copied, photocopied, or duplicated in any form by any means or (ii) redistributed without BOB Capital Markets Ltd. s prior written consent. No part of this document may be distributed in Canada or used by private customers in the United Kingdom. Equity research 5